TERAMEF OD
Composition:Mesalamine Prolonged Release 1.2gm
Use For:TERAMEF OD (Mesalamine Prolonged Release 1.2gm Tablets) is a high-strength anti-inflammatory medication specifically formulated for the treatment and maintenance of remission in mild to moderate ulcerative colitis. Mesalamine, also known as 5-aminosalicylic acid (5-ASA), works locally in the colon to reduce inflammation by inhibiting the production of prostaglandins and other inflammatory mediators. The prolonged-release formulation of TERAMEF OD ensures targeted and sustained delivery of the active ingredient throughout the gastrointestinal tract, particularly in the distal colon where inflammation is most prevalent in ulcerative colitis.TERAMEF OD is usually administered once daily, offering improved patient compliance and consistent therapeutic levels, making it suitable for both active flare-ups and long-term maintenance therapy.
✅ TERAMEF OD (Mesalamine 1.2g (Prolonged Release Tablets))
Product Overview:
TERAMEF OD contains Mesalamine, a potent anti-inflammatory medication used for the treatment of ulcerative colitis and other inflammatory bowel diseases (IBD). It works by reducing inflammation in the colon, preventing flare-ups, and promoting remission in patients with chronic conditions like ulcerative colitis and Crohn’s disease. The prolonged-release formulation ensures consistent drug release over time, minimizing side effects and enhancing patient compliance.
This formulation is especially beneficial for patients with moderate-to-severe ulcerative colitis who require long-term management. TERAMEF OD offers a controlled release of Mesalamine, which leads to more effective targeting of the inflamed areas of the colon, providing relief from symptoms such as abdominal pain, diarrhea, and rectal bleeding. It is ideal for PCD franchises looking to offer a high-quality gastrointestinal therapeutic option and for companies seeking a reliable product for third-party manufacturing.
Key Features:
Contains Mesalamine 1.2g for effective anti-inflammatory action
Prolonged release formulation for sustained therapeutic effects
Targets the colon directly, providing localized treatment for inflammatory bowel diseases (IBD)
Improved patient compliance due to fewer doses needed throughout the day
Manufactured in a WHO-GMP certified facility
Available for PCD franchise and third-party manufacturing
High stability, packaging, and shelf life
Benefits:
Reduces Inflammation: Provides relief from symptoms of ulcerative colitis and other IBDs
Prevents Disease Flare-ups: Helps in maintaining remission and reducing relapse rates
Improves Quality of Life: Reduces abdominal pain, diarrhea, and rectal bleeding
Convenient Dosage: Prolonged-release ensures fewer doses per day, improving adherence to treatment
Safe for Long-Term Use: Suitable for long-term management of chronic conditions like ulcerative colitis
How to Use:
Dosage: 1 tablet (1.2g) per day, or as directed by a healthcare provider
Administration: Should be taken orally with or without food
Duration: Use for an extended period as per doctor’s recommendation
Monitoring: Regular monitoring of kidney function may be advised during prolonged use
For PCD Pharma Franchise:
We offer TERAMEF OD as part of our gastrointestinal portfolio for PCD Pharma franchises. With promotional support, visual aids, monopoly rights, and competitive margins, you can expand your market reach and build a trusted presence in gastrointestinal healthcare.
For Third-Party Manufacturing:
We provide third-party manufacturing services for Mesalamine Prolonged Release 1.2g tablets. Our services include customized private labeling, flexible packaging options, bulk orders, and export facilities. All manufacturing adheres to GMP/ISO standards, ensuring the highest quality and consistency.
KEYWORDS
Mesalamine 1.2g tablets, Mesalamine prolonged-release, TERAMEF OD tablets, ulcerative colitis treatment, IBD medication tablets, Mesalamine tablets PCD, gastrointestinal franchise, ulcerative colitis PCD products, mesalamine PCD supplier, Mesalamine for chronic IBD, gastrointestinal disorder franchise, ulcerative colitis remission, Mesalamine for Crohn’s disease, pro-inflammatory bowel disease tablets, Mesalamine extended-release tablets, IBD management tablets, PCD franchise for gastrointestinal medication, GI disorder franchise, Mesalamine anti-inflammatory treatment, prolonged-release tablets for IBD, Mesalamine drug franchise, gastrointestinal tablets for PCD, Mesalamine 1.2g PCD supply, Mesalamine ulcerative colitis medication, PCD for IBD medication, GI health franchise products, Mesalamine franchise company, Mesalamine therapy for ulcerative colitis, Mesalamine tablets for IBS, Mesalamine colitis relief, gastrointestinal anti-inflammatory tablets, PCD supplier for ulcerative colitis, Mesalamine treatment for IBD, prolonged-release gastrointestinal tablets, GI tract inflammation medication, mesalamine tablets franchise, chronic bowel disease medication, GI ulcerative colitis relief, Mesalamine bulk supplier, Mesalamine tablets for gastrointestinal health, Mesalamine anti-inflammatory supplier, effective IBD therapy, Mesalamine for bowel disease, gastrointestinal pharmaceutical products, Mesalamine PCD company, GI inflammation tablets PCD, best gastrointestinal tablets PCD, Mesalamine 1.2g gastrointestinal tablets, high-quality IBD medication, Mesalamine medication for gut, ulcerative colitis drug franchise, Mesalamine bulk tablet supplier, PCD for bowel disease tablets, Mesalamine PCD marketing, Mesalamine anti-inflammation tablet supply, Mesalamine gastrointestinal therapy, gastrointestinal drug franchise, Mesalamine extended-release supplier, PCD Mesalamine franchise, IBD remission tablets, Mesalamine ulcerative colitis control, Mesalamine third-party manufacturing.Mesalamine prolonged-release tablets, third-party Mesalamine manufacturing, bulk Mesalamine tablets, third-party gastrointestinal tablets, Mesalamine contract manufacturer, Mesalamine tablet private label, bulk Mesalamine production, contract manufacturing for IBD medication, Mesalamine third-party supplier, Mesalamine tablets production facility, Mesalamine 1.2g tablets contract manufacturing, third-party manufacturing Mesalamine, Mesalamine 1.2g tablet exporter, contract manufacturing for gastrointestinal tablets, Mesalamine anti-inflammatory tablets supplier, Mesalamine private label manufacturing, third-party contract manufacturer Mesalamine, export Mesalamine tablets, GMP certified Mesalamine tablet production, Mesalamine third-party contract manufacturer, Mesalamine tablets for ulcerative colitis, Mesalamine tablets for IBD contract production, Mesalamine third-party supply services, Mesalamine bulk tablet contract production, third-party gastrointestinal tablet supplier, Mesalamine 1.2g third-party production, Mesalamine export manufacturer, Mesalamine tablet GMP contract, IBD treatment tablet production, Mesalamine tablet export, Mesalamine for Crohn’s disease third-party manufacturer, Mesalamine bulk supplier India, Mesalamine production for export, third-party gastro tablet packager, private labeling for Mesalamine, Mesalamine tablet bulk orders, Mesalamine anti-inflammatory contract manufacturer, Mesalamine tablet packaging service, third-party gastrointestinal drug supply, Mesalamine tablets in bulk, Mesalamine third-party manufacturing service, gastrointestinal tablets third-party production, bulk Mesalamine tablets manufacturing, Mesalamine private label services, third-party gastrointestinal medication, Mesalamine IBD management production, Mesalamine tablet production export, bulk gastrointestinal medication manufacturer, Mesalamine for ulcerative colitis private label, third-party production of Mesalamine tablets, third-party Mesalamine export services, contract manufacturing for gastrointestinal health tablets, Mesalamine contract supply India, Mesalamine 1.2g tablets contract packager, Mesalamine supplier for export, Mesalamine bulk tablet export, Mesalamine in IBD treatment, third-party manufacturing of Mesalamine capsules, gastrointestinal treatment production for export.Mesalamine for ulcerative colitis PCD, PCD franchise for IBD medications, Mesalamine 1.2g tablets for IBS, ulcerative colitis PCD tablets, Mesalamine for chronic gastrointestinal issues, Mesalamine treatment franchise, ulcerative colitis relief tablets PCD, gastroenterology PCD franchise, Mesalamine for bowel disease, gastrointestinal therapeutic PCD, Mesalamine 1.2g gastrointestinal tablets franchise, gastrointestinal disorder tablets for franchise, Mesalamine anti-inflammatory PCD supplier, GI disorder treatment franchise, Mesalamine ulcerative colitis control tablets, gastrointestinal treatment tablets PCD, Mesalamine PCD franchise supplier, gastrointestinal anti-inflammatory tablets franchise, Mesalamine for IBD treatment, PCD for gastrointestinal tablets, best PCD franchise for gastrointestinal medication, Mesalamine gastrointestinal inflammation PCD, ulcerative colitis medication PCD franchise, gastrointestinal health PCD products, Mesalamine anti-inflammatory solution, long-term IBD management tablets, Mesalamine for Crohn's disease PCD, Mesalamine for colon inflammation, gastroenterology drugs PCD, Mesalamine GI tract inflammation PCD, Mesalamine PCD marketing support, Mesalamine franchise distributor, high-quality gastrointestinal tablets, Mesalamine ulcerative colitis treatment PCD, Mesalamine for IBD remission, gastrointestinal disease treatment PCD, Mesalamine anti-inflammatory treatment PCD, Mesalamine extended-release tablets franchise, Mesalamine ulcerative colitis remission, GI inflammation tablets PCD, Mesalamine for bowel disorder PCD, PCD for long-acting gastrointestinal tablets, gastrointestinal ulcer tablets franchise, Mesalamine for gut inflammation, gastrointestinal pharmaceutical franchise, PCD Mesalamine supplier, Mesalamine for digestive tract health, Mesalamine anti-inflammatory medication franchise, ulcerative colitis PCD supplier, Mesalamine bowel disease PCD, ulcerative colitis management PCD, Mesalamine for chronic IBD management, gastrointestinal health tablets franchise, effective Mesalamine tablets PCD, Mesalamine for gastrointestinal care, Mesalamine franchise India, gastrointestinal disorder medication PCD, Mesalamine anti-inflammatory franchise, high-quality GI disorder tablets, Mesalamine for long-term ulcerative colitis relief, PCD supplier for Mesalamine tablets, gastrointestinal drug franchise India, Mesalamine for chronic bowel conditions, Mesalamine GI healing tablets PCD, gastro tablets for ulcerative colitis, Mesalamine ulcerative colitis prevention, Mesalamine therapeutic tablets for IBD, PCD company for gastrointestinal medication, Mesalamine for Crohn’s disease remission, Mesalamine tablets for IBD flare-ups, gastro treatment medication for franchise, PCD for colon inflammation tablets, Mesalamine ulcerative colitis dosage, Mesalamine bowel healing tablets, Mesalamine for gastrointestinal therapy, PCD gastrointestinal products, Mesalamine therapeutic support for IBD, gastrointestinal PCD brand for Mesalamine, Mesalamine ulcerative colitis prevention tablets.